Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2775 of 2873 entries
View as:

A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions

Phase: N/A Priority: Normal
NCT ID: NCT06308419 Org: User:
Start: 08/14/24 End: 02/01/31 Due: 02/01/32

Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women

Phase: N/A Priority: Normal
NCT ID: NCT00539162 Org: User:
Start: 07/02/01 End: 11/30/28 Due: 11/30/29

Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04017650 Org: User:
Start: 06/14/19 End: 06/30/25 Due: 06/30/26

Catheter Related - Gram Positive Bloodstream Infections

Phase: N/A Priority: Normal
NCT ID: NCT00467272 Org: User:
Start: 03/31/07 End: 09/30/12 Due: 09/30/13

Study of Cytoreductive Surgery and Hyperthermic Intrathoracic Pleural Chemotherapy (HITC) With Escalating Doses for Children and Adolescents With Unilateral Pleural Malignancy

Phase: N/A Priority: Normal
NCT ID: NCT01998529 Org: User:
Start: 08/20/14 End: 08/25/20 Due: 08/25/21

Comprehensive Nutritional Geriatric Assessments in Identifying Malnutrition in Older Cancer Participants

Phase: N/A Priority: Normal
NCT ID: NCT03035604 Org: User:
Start: 01/24/17 End: 06/30/27 Due: 06/30/28

Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants

Phase: N/A Priority: Normal
NCT ID: NCT03546972 Org: User:
Start: 12/17/17 End: 11/30/26 Due: 11/30/27

Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord

Phase: N/A Priority: Normal
NCT ID: NCT02713269 Org: User:
Start: 08/29/16 End: 08/28/25 Due: 08/28/26

A Phase II Study of Cladribine and Low Dose Cytarabine in Combination With Venetoclax, Alternating With Azacitidine and Venetoclax, in Patients With Higher-risk Myeloproliferative Chronic Myelomonocytic Leukemia or Higher-risk Myelodysplastic Syndromes With Excess Blasts

Phase: N/A Priority: Normal
NCT ID: NCT05365035 Org: User:
Start: 09/23/22 End: 12/01/25 Due: 12/01/26

Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00525031 Org: User:
Start: 08/31/06 End: 06/30/16 Due: 06/30/17

Gemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT00478361 Org: User:
Start: 04/30/07 End: 06/30/15 Due: 06/30/16

18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

Phase: N/A Priority: Normal
NCT ID: NCT02379377 Org: User:
Start: 02/15/22 End: 05/31/25 Due: 05/31/26

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00299182 Org: User:
Start: 03/31/06 End: 04/30/12 Due: 04/30/13

Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00062023 Org: User:
Start: 06/30/03 End: 05/31/06 Due: 05/31/07

Prospective Study of Colonoscopic Resection of Large Polyps and Flat Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02332772 Org: User:
Start: 04/30/15 End: 04/30/25 Due: 04/30/26

Pleural Catheters Versus Thoracoscopic Pleurodesis

Phase: N/A Priority: Normal
NCT ID: NCT01117740 Org: User:
Start: 04/30/10 End: 04/30/16 Due: 04/30/17

Irinotecan (Camptosar) in Patients With Advanced Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT00509860 Org: User:
Start: 03/31/03 End: 01/31/12 Due: 01/31/13

Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00871923 Org: User:
Start: 03/26/09 End: 12/04/19 Due: 12/04/20

Implementation of Digital Vital Sign Monitoring to Decrease Sleep Interruption and Enhance Recovery in Phase II of the PROmoting Sleep, Patient Engagement and Recovery (PROSPER) Project

Phase: N/A Priority: Normal
NCT ID: NCT05456360 Org: User:
Start: 03/01/23 End: 10/30/23 Due: 10/30/24

Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology

Phase: N/A Priority: Normal
NCT ID: NCT06336642 Org: User:
Start: 06/11/24 End: 03/31/32 Due: 03/31/33

Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix

Phase: N/A Priority: Normal
NCT ID: NCT05063916 Org: User:
Start: 02/28/22 End: 08/01/25 Due: 08/01/26

Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT06121232 Org: User:
Start: 11/02/23 End: 04/01/26 Due: 04/01/27

Oncology Dashboard for the Improvement of Operational Efficiency and Patients Outcomes in Patients With Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05216029 Org: User:
Start: 10/01/15 End: 12/31/25 Due: 12/31/26

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Phase: N/A Priority: Normal
NCT ID: NCT05054413 Org: User:
Start: 04/15/21 End: 05/01/26 Due: 05/01/27

Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04265430 Org: User:
Start: 09/17/18 End: 09/01/31 Due: 09/01/32